Are societal perspectives on resource allocation in health care reflected in recommendations and decisions about funding of costly end of life technologies?
Projectomschrijving
Resultaten
Er zijn drie visies gevonden. In de visie ‘Gelijk recht op zorg’ (61% van de bevolking) heeft iedereen recht op zorg en mag er geen voorkeur uitgaan naar bepaalde patiënten boven anderen. In de visie ‘Grenzen aan de zorg’ (26%) zijn er grenzen aan wat de zorg kan doen voor patiënten en zijn preventie en kwaliteit van leven belangrijk. In de visie ‘Effectieve en efficiënte zorg’ (7%) staat het behalen van de hoogste gezondheid in de bevolking centraal. Zes procent had geen duidelijke voorkeur. Geen van de visies gaf prioriteit aan behandelingen aan het einde van het leven.Producten
Auteur: Wouters, Sofie, van Exel, Job, Baker, Rachel, B.F. Brouwer, Werner
Magazine: Value in Health
Link: https://doi.org/10.1016/j.jval.2016.09.544
Verslagen
Eindverslag
The ageing of our population, the persistently rising demand for care and the continuously increasing possibilities for treatment threaten the affordability of our health care system. In order to be able to continue providing good care to all, society needs to determine which treatments should remain being reimbursed (and which not). This study has used interviews, focus group sessions and surveys to investigate which criteria the public in the Netherlands considers important for decisions about how to spend the health care budget optimally. A majority of the population considers healthcare as a right, appears to negate that there are limits to healthcare, and therefore does not want to make choices. Everything that is medically possible and desired by patients should be possible. Another part of the population seems to accept that choices need to be made, and appear to prefer quality to length of life, children to adults, and as much health as possible from the available budget. There appears to be no support among the public for making a special case for certain patient groups, as for instance expensive treatments for cancer.